Special report: Twenty extraordinary women blazing trails in biopharma R&D — Covid-19 and beyond
- Dec 10, 2020
- 2 min read
Updated: Sep 13, 2022
In the second year of Endpoints News’ budding tradition of highlighting women blazing trails in biopharma R&D, we’ve seen a number of firsts.
For the first time, the biggest story in R&D is also top of mind for a world anxious to end the most devastating health crisis in decades. With its sweeping effects, the Covid-19 pandemic is turning the daily routines for many working women upside down, taking a toll on not just their physical and mental health, but also their career prospects. At the same time, the biotech industry is doing some serious soul searching with a new scorecard and plan for diversity and inclusion.
It is more important than ever to shine light on the growing number of women who have scaled the heights of drug discovery and development even though the odds are stacked against them, breaking open paths in labs and C-suites that can be followed by future generations, some of whom they are also actively nurturing and mentoring.
We set out this year with a dual goal: to celebrate women at the forefront of subduing Covid-19 — either with diagnostics, vaccines or treatments — and to honor those working day in and day out to address other equally pressing medical needs.
Profiles are, by definition, snapshots. Some of the women recognized in our 2019 special report have since become household names: Jennifer Doudna became a Nobel laureate for her pioneering work in CRISPR gene editing and Özlem Türeci helped create the world’s first vaccine proven effective against Covid-19. Even in the short period since we interviewed this year’s honorees, we’ve seen them mark new milestones, from taking a biotech public to scoring historic clinical data and regulatory authorizations.
We hope our profiles capture a unique moment in history as these highly accomplished figures take us with them down memory lane to illustrate what brought them to this moment and how they are helping other women do the same — if not even more.
Effective decision making frameworks finance support better forecasting, helping companies plan budgets and allocate resources more efficiently.
This is where the cold chain becomes critical. A single temperature deviation can spoil a batch of medicine worth thousands of dollars and, more importantly, delay patient care. In a region like the UAE, which has established itself as a global hub for healthcare and logistics, the infrastructure has to be perfect. For biopharma companies operating there, or for the distribution networks bringing these innovations to the Middle East, finding the right logistics partner is key. They require a refrigerated truck rental uae service that doesn't just provide a vehicle, but guarantees the integrity of their cold chain with advanced telematics and strict temperature control. For instance, companies need access to fleets that offer precise temperature logging and HACCP compliance…
What an inspiring tribute to the incredible women driving innovation in biopharma R&D! Their contributions during Covid-19 and beyond highlight the power of dedication, scientific excellence, and leadership in advancing global health. Supporting such groundbreaking work also requires strong compliance and operational foundations—areas where Regulatory Outsourcing Consultancy ensures that research, development, and approvals meet the highest international standards.
Modern Dubai Apartments combine sleek design, smart layouts, and world-class amenities to create the perfect urban lifestyle. Located in prime areas, these residences offer convenience, comfort, and style. With advanced facilities, stunning views, and vibrant surroundings, modern apartments in Dubai are ideal for both investors and contemporary city living.
Step aboard a super yacht Dubai experience with Supernova Yachts—perfect for elite celebrations, film shoots, or luxury getaways. Our mega yachts redefine opulence with jacuzzis, lounges, chefs, and crew. Discover Dubai’s coastline like royalty.